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Abstract
The advent of web-based treatments for anxiety disorders creates a need for quick and valid online screening instruments,
suitable for a range of social groups. This study validates a single-item multimedia screening instrument for agoraphobia,
part of the Visual Screener for Common Mental Disorders (VS-CMD), and compares it with the text-based agoraphobia items
of the PDSS-SR. The study concerned 85 subjects in an RCT of the effects of web-based therapy for panic symptoms. The VS-
CMD item and items 4 and 5 of the PDSS-SR were validated by comparing scores to the outcomes of the CIDI diagnostic
interview. Screening for agoraphobia was found moderately valid for both the multimedia item (sensitivity.81, specificity.66,
AUC.734) and the text-based items (AUC.607–.697). Single-item multimedia screening for anxiety disorders should be
further developed and tested in the general population and in patient, illiterate and immigrant samples.
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Introduction
Anxiety disorders are the most prevalent type of mental
disorders, affecting about 17% of all people at least once in their
lifetime [1]. They can improve with suitable psychological and/or
drug therapy [2–3], but only one in four people with anxiety
symptoms seek help [4].
A more accessible alternative to face-to-face therapy could be
Internet-based interventions. These have proven to be as effective
as face-to-face help for anxiety disorders [5] and they have several
advantages. First, users can receive the treatment in the comfort of
their homes and do not have to travel to a therapist or mental
health centre. Second, even guided web-based interventions -
which have been found more effective than unguided ones [6] -
can take less therapist time than face-to-face help [7–8]. Third, the
information can be presented in an attractive manner with audio,
images and animations [9]. Fourth, outcomes of screening and
progress monitoring can be instantly available to a health care
provider, as well as to the users themselves if the programme is
interactive or the screening leads to advice or redirection.
Both in research and in clinical practice, web-based therapy
requires web-based measures to direct help-seekers to appropriate
information, screen them for suitability for therapy, and monitor
progress. Evidence suggests that web-based measures can be valid
[10] as well as time-efficient and economically efficient [11], for
example for assessing symptoms related to panic disorder (PD)
[11].
For depression and anxiety disorders, web-based screening
questionnaires are usually digital versions of paper-pencil mea-
sures, even though psychometric properties may be different when
a screener is placed on the web [12,13,14]. Some studies revalidate
existing questionnaires for online use, e.g. for panic symptoms
[15], social phobia [16] and generalised anxiety [13]. The field of
Internet intervention research is innovating rapidly [17] and
developing web-based psychometric measures. Examples of web-
based questionnaires for common mental disorders are the
Internet-Based Self-Assessment Program for Depression (ISP-D)
[18], the Web-Based Depression and Anxiety Test (WB-DAT)
[19] and the Web Screening Questionnaire (WSQ) [20]. These
questionnaires have moderate to good screening properties
(sensitivity.63 to 1.00, specificity.44 to.97).
An additional advantage of the WSQ and the ISP-D is the use
of single screening items. A single short item can quickly direct a
user either to more elaborate items measuring symptom severity or
to psycho-education [18,20]. Single-item screening is a quick
means to screen for mood and anxiety disorders and has been
proven to be valid [13,18–21], while taking less time than multi-
item instruments. Some studies have shown single-item instru-
ments are just as accurate as multi-item instruments [20–21], but,
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in general, it can be assumed that when an instrument gathers
more data, its validity increases.
Existing web-based instruments may differ from paper-pencil
questionnaires by using answers to instantly adapt the measure or
the presentation of only one item per screen [22], but they are still
text-based. The use of multimedia could aid the understanding of
items, particularly by users who have difficulty reading. Studies
have shown that the use of multimedia for educational purposes
can result in better comprehension of the material presented,
especially when images or animations are combined with text or
narration [23–24].
A questionnaire that employs visual and auditory elements
could be more appealing in general and also better suit people
with lower reading levels. This motivated the development of the
Visual Screener for Common Mental Disorders (VS-CMD) [25].
The VS-CMD is a 12-item questionnaire that screens for
symptoms of anxiety disorders, depression, alcohol abuse and
suicidal ideation. Its items consist of simple text, voice narration
and images or animations.
The current study validates a single item of the VS-CMD which
screens for agoraphobic symptoms. The data derive from a
randomised controlled trial (RCT) of web-based self-help for
subclinical to mild panic disorder (PD) in adults in the general
population [26]. Randomisation of participants in the RCT is
stratified for agoraphobic symptoms, because that condition can
complicate certain elements of the self-help course, such as
exposure exercises. That stratification is based on an item of the
Panic Disorder Severity Scale – Self Report (PDSS-SR) [27], a
validated, text-based questionnaire. Because a diagnostic interview
is used, predictive validity can be established for both the PDSS-
SR agoraphobia item and the VS-CMD agoraphobia item.
The aim of this study is twofold. First, we assess the validity of
web-based single-item screening for agoraphobic symptoms.
Second, we compare the multimedia agoraphobia item of the
VS-CMD to the text-based agoraphobia items of the PDSS-SR,
checking whether stratification for the RCT based on the
agoraphobia item of the VS-CMD would be as valid.
Method
1. Ethics Statement
The RCT protocol was approved by the Medical Ethics Review
Committee of the VU University Medical Centre (METc VUmc)
in Amsterdam. Written informed consent was obtained from all
participants.
2. Participants
Participants were recruited among the general Dutch popula-
tion by means of articles on a news website, a Facebook
advertisement campaign, messages on panic- or anxiety-related
online forums, banners on health-related websites and advertise-
ments in newspapers. They were invited to enter a randomised
controlled trial (RCT) comparing a web-based course for panic
symptoms to a waiting-list control group. For more detailed
information on the RCT, see the trial protocol [26]. Applicants
could apply by printing and signing the informed consent form,
which could then be scanned and e-mailed or returned by post.
Participation required only an e-mail address and a phone
number. Multiple entries by a single participant were unlikely as
every participant was interviewed by phone. Data were collected
from March-December 2010.
The study population consisted of adults with subclinical or
mild panic disorder (PD). Inclusion criteria were: aged at least
18, Internet access, and subclinical or mild PD (PDSS-SR scores
of 5–15). Individuals with too mild (PDSS-SR scores of 1–4) or
too severe panic symptoms (scores of 16 or higher) were thereby
excluded, as were people reporting moderate to high suicide risk.
Those with severe panic or suicide risk were e-mailed advice to
contact their general practitioner. The RCT was registered in the
Netherlands Trial Register, part of the Dutch Cochrane Centre
(NTR1639).
3. Instruments
The visual screener for common mental disorders (VS-
CMD). The VS-CMD is based on the Web Screening
Questionnaire (WSQ) [20]. The WSQ is a 15-item text-based
screening instrument for common mental disorders. It has proven
a valid screener for social phobia, PD with agoraphobia,
agoraphobia (without PD), obsessive-compulsive disorder and
alcohol abuse/dependence (sensitivity .72–1.00; specificity .63–
.80) [20]. Its psychometric properties were slightly more modest
for major depressive disorder, generalised anxiety disorder,
posttraumatic stress disorder, specific phobia and PD without
agoraphobia (sensitivity: .80–.93; specificity: .44–.51). Note that
these data reflect the validity of the WSQ compared to full-blown
diagnoses ascertained by the CIDI by telephone [20].
The VS-CMD consists of 12 items and intends to measure
clinically relevant symptoms of major depressive disorder,
generalised anxiety disorder, PD, agoraphobia, specific phobia,
social phobia, posttraumatic stress disorder, obsessive-compulsive
disorder, alcohol abuse and suicidal ideation. Depression and
suicidal ideas are each detected by two items, while other topics
are detected by single items. Each item appears on a separate
screen, which has been shown to be preferred by patients while
being just as valid as multiple items per screen [22]. The items
consist of illustrations or animations supported by a single, simply
written sentence, which is also provided in spoken form. Currently,
the VS-CMD is available in Dutch, English, Moroccan Arabic,
Spanish and Turkish. There are male and female versions, each
with corresponding images and voice-overs. The translations and
voice-overs were performed by native speakers. The name ‘‘Visual
Screener’’ has been chosen by the developers to emphasise the
visual/graphic functionalities of this instrument.
The VS-CMD was compared with the WSQ among Dutch
university students of ethnic Dutch and ethnic Turkish back-
grounds. In the Dutch sample, the agoraphobia item did not show
a significant association with its WSQ counterpart, but it did in the
Turkish sample. The agoraphobia item in the Dutch VS-CMD
(item 5) was therefore rephrased, without changing the graphics
[25].
Item 5 was developed to screen for clinically relevant
agoraphobic symptoms, i.e. symptoms that may not meet criteria
of a full-blown disorder according to the DSM-IV-TR, but are a
disability for the patient and do warrant treatment. According to
the DSM-IV-TR, agoraphobia means anxiety and avoidance
related to places or situations from which escape might be difficult
(or embarrassing) or in which help may not be available in the
event of having an unexpected or situationally predisposed panic
attack or panic-like symptoms [28]. The DSM-IV-TR classifies
agoraphobia as subordinate to PD. It can either be diagnosed as
PD with agoraphobia, or as agoraphobia without history of PD.
The current paper focuses on full-blown agoraphobia that
accompanies panic symptoms, first, because all of the participants
suffer from subclinical to full-blown PD and second, because the
gold standard (the CIDI) only makes a distinction between no
diagnose and full-blown diagnose. The VS-CMD item visually
depicts 4 situations that could frighten people with agoraphobic
symptoms, supported by the question: ‘Are you afraid of crowded
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Figure 1. Item 5 of the VS-CMD.
doi:10.1371/journal.pone.0038480.g001
Figure 2. Flow chart.
doi:10.1371/journal.pone.0038480.g002
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places where it is difficult to leave quickly?’ (Figure 1). The VS-
CMD yields a dichotomous prediction for agoraphobic symptoms
(the user answers ‘yes’ or ‘no’).
Participants in the present study completed all 12 items of the
VS-CMD. A built-in clock registered how much time each
participant spent on completing the instrument.
Panic disorder severity scale-self report (PDSS-SR). The
full PDSS-SR consists of 7 items and is a valid instrument to screen
for PD with adequate psychometric properties when compared to
the interview form of the Panic Disorder Severity Scale [27] [29].
Each item consists of an introduction to a specific symptom and 5
answer options scoring 0 to 4. Item 4 (PDSS-SR-4) assesses
agoraphobic avoidance and item 5 (PDSS-SR-5) interoceptive
avoidance, which means avoidance of situations that could induce
physiological responses similar to those occurring in an anxiety
crisis. PDSS-SR-5 was included in the present study, because
agoraphobic behaviour associates with interoceptive avoidance. In
the RCT, the stratification of the randomisation was based on the
PDSS-SR-4 score alone, scores of 2 or higher denoting agora-
phobic symptoms. PDSS-SR-4 correlates with measures of
agoraphobic avoidance and cognitions [30]. The cut-off point of
2 is consistent with that in other studies [30,31]. The present study
used the Dutch version of the PDSS-SR [32].
Composite international diagnostic interview
(CIDI). Diagnosis of agoraphobia was obtained using the 12-
month version of the CIDI [33–34]. The CIDI is an extensive,
fully structured and valid diagnostic interview to assess ICD-10
and DSM-IV Axis-I diagnoses [35–36]. The agoraphobia section
of the CIDI is separate from the PD section and for the present
study, only the outcome of the agoraphobia section was
considered. The CIDI yields a dichotomous outcome: diagnosis
or no diagnosis. The interview was administered by phone by a
trained interviewer. Diagnostic interviews by telephone give highly
similar results compared to face-to-face interviews [37].
Other variables. Other variables assessed included gender,
age, nationality and education. Suicide risk was measured using 5
self-report questions derived from the Mini-International Neuro-
psychiatric Interview (MINI) [38–39].
4. Procedure
Candidates for RCT participation completed a battery of online
questionnaires. Questions on demographic data preceded the
PDSS-SR, which was followed by the questions pertaining to
suicide risk. Applicants who met the criteria based on the PDSS-
SR and suicide risk scores were included in the sample, and they
proceeded to complete questionnaires that assessed baseline values
for the RCT outcome variables. These data are not reported in
this paper. Each page of the demographics and mental health
questionnaires contained two or three items. The VS-CMD was
filled in last, with each page displaying only one item. Subjects
could go back to previous questions, but could not go forward
before answering the current question. Completing all question-
naires took about 20 minutes. Data were stored digitally in a non-
public database requiring a username and password to access.
Within two weeks after completing the VS-CMD and other
questionnaires, each RCT participant was phoned for the CIDI
and was randomly allocated immediately thereafter to the
intervention group or the control group. All data used in the
current paper were collected before randomisation.
5. Analyses
First, the sensitivity and specificity of the VS-CMD agoraphobia
item were calculated by comparing the participants’ scores to their
CIDI diagnoses. This was also done for PDSS-SR-4. There is no
consensus on which levels of sensitivity and specificity are
acceptable, because those depend on the purpose, costs and
benefits of the test [40]. Since the purpose of the Visual Screener is
to detect clinically relevant problems, and not only full-blown
disorders, sensitivity values of.70 or higher and specificity values
of.40 or higher were considered satisfactory.
Second, the area under the ROC curve (AUC) was established
for VS-CMD item 5, PDSS-SR-4, PDSS-SR-5 and PDSS-SR
items 4 and 5 combined. The combination of PDSS-SR items 4
and 5 was tested because the combined items could have
potentially yielded a larger AUC than the individual items. The
AUC is a measure of validity established by plotting a measure’s
sensitivity against 1 – specificity. It can range from.500 (worthless
test) to 1 (perfect test). Areas under the curve of .500–.700 are said
to reflect low accuracy, .700–.900 moderate accuracy and .900–
1.000 high accuracy [41]. Differences between the AUCs of the
different items were calculated using the formula of Hanley and
McNeil [42].
Other analyses included mean scores for demographics and
mean time to complete the VS-CMD. For all analyses, alpha was
set at.05. Analyses were conducted with SPSS for Windows,
version 17.
Results
1. Sample
Of 368 applicants for the RCT, 85 (23%) were included in the
present study. Of those who completed the screening question-
Table 1. Demographics.
m (SD) n (%)
Mean age 35.7 (11.1)
Gender: female 59 (69)
Born in the Netherlands 78 (92)
High education (bachelors equivalent or higher) 42 (49)
Prevalence of panic disorder (diagnosed with CIDI) 64 (75)
Prevalance of agoraphobia (diagnosed with CIDI) 53 (62)
n=85.
doi:10.1371/journal.pone.0038480.t001
Table 2. Agoraphobia outcomes of PDSS-SR item 4 and CIDI, cut-off = 2. n = 85.
CIDI agoraphobia positive CIDI agoraphobia negative
PDSS-SR agoraphobia positive 17 4
PDSS-SR agoraphobia negative 36 28
Sensitivity = .32, specificity = .88.
doi:10.1371/journal.pone.0038480.t002
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naires (313), 106 did not meet the RCT inclusion criteria and 64
did not complete all questionnaires or were unavailable for the
telephone interview. Data of 58 participants could not be saved or
were lost due to a mistake by the company hosting the VS-CMD
database. See figure 2 for a flow chart. Of the 85 participants in
the ultimate sample, 64% were female and the age range was 19 to
60 (M = 35.7, SD = 11.1). Most (92%) were born in the
Netherlands and 49% had academic degrees (equivalent of
bachelor’s or higher) (table 1).
2. Predictive Validity of PDSS-SR
In the CIDI interviews, 53 participants were diagnosed with
agoraphobia. At a cut-off score of 2, PDSS-SR item 4 screened 21
participants positively for agoraphobic symptoms, corresponding
to a sensitivity of.32, a specificity of.88 and an AUC of.684 (95%
CI: .568–.810; see table 2 and figure 3). The optimal cut-off point
for PDSS-SR-4 was 1, which has a sensitivity of.76 and a
specificity of.56. Item 5 of the PDSS-SR predicted agoraphobia
poorly, with an AUC of.607 (95% CI: .484–.730; figure 3); its
optimal cut-off was 1, with a sensitivity of.42 and a specificity
Figure 3. ROC Curves of VS-CMD item 5, PDSS-SR-4, PDSS-SR-5, and PDSS-SR items 4 and 5 combined. Footnote: PDSS-SR-4: AUC.684;
PDSS-SR-5: AUC.607; PDSS-SR items 4 and 5 combined: AUC.697; VS-CMD item 5: AUC.734.
doi:10.1371/journal.pone.0038480.g003
Table 3. Agoraphobia outcomes of VS-CMD item 5 and CIDI. n = 85.
CIDI agoraphobia positive CIDI agoraphobia negative
VS agoraphobia positive 43 11
VS agoraphobia negative 10 21
Sensitivity = .81, specificity = .66.
doi:10.1371/journal.pone.0038480.t003
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of.81. Combining item 4 and 5, predictive validity was slightly
improved to an AUC of.697 (95% CI: .583–.810; figure 3).
3. Predictive Validity of VS-CMD
The VS-CMD agoraphobia item identified 54 participants as
reflecting possible cases of agoraphobia. The sensitivity of the VS-
CMD agoraphobia item was.81, the specificity.66 and the
AUC.734 (95% CI: .619–.849), indicating moderate accuracy
[41] (see table 3 and figure 3). The VS-CMD item predicted
agoraphobia slightly better than PDSS-SR-4 (agoraphobic avoid-
ance), although this difference (mean difference = 0.05) was not
significant (z = 0.61, p = .27). PDSS-SR-5 (interoceptive
avoidance) yielded a lower AUC than the VS-CMD, but this
difference (0.127) was short of significance (z = 1.57, p = .06).
4. Completion Time for VS-CMD
The entire VS-CMD was completed by 66% of the participants
(n = 58) in 2 to 3 minutes. The overall average was 3.6 minutes
(SD=3.7). Completion times did not differ by gender (t=2.267,
p= .79), but did slightly correlate with age (r = .27, p= .01), with a
higher age associated with a longer time to complete.
Discussion
The audiovisual agoraphobia item of the Visual Screener for
Common Mental Disorders (VS-CMD) could be a valid instru-
ment to screen for agoraphobic symptoms. In the current sample
of people with panic symptoms, it predicted the outcome of a
diagnostic interview with moderate sensitivity and specificity. In
terms of AUC, it performed slightly better than PDSS-SR-4,
though not significantly. PDSS-SR-5 performed poorly. A
combination of PDSS-SR items 4 and 5 might slightly improve
the ability of the PDSS-SR to screen for (full-blown) agoraphobia.
The multimedia VS-CMD item screened for agoraphobia at least
as well as the text-based PDSS-SR agoraphobia items combined,
despite the VS-CMD item’s minimal text and dichotomous
outcome. The entire 12-item VS-CMD is a brief assessment,
taking about 3 minutes to complete, which is about 15 seconds per
item. These results indicate the VS-CMD could be just as valid as
text-based instruments, while it should be more intelligible for
people with difficulty reading due to its reliance on images and
audio.
In this study, the sensitivity of PDSS-SR-4 was very low at cut-
off point 2. Perhaps the cut-off point could be lowered to 1 at the
expense of specificity. Wuyek et al. [29] have argued that while the
PDSS-SR is a valid questionnaire, it is advisable not to rely on its
single items. In the RCT from which we obtained the data for the
current study, PDSS-SR-4 was used to stratify the randomisation
for agoraphobia. Our results imply that VS-CMD item 5 would
have been an equally good or better predictor of agoraphobia
diagnosis in the sample.
The psychometric properties of the multimedia VS-CMD
agoraphobia item (sensitivity.81, specificity.66 and AUC.734;
95% CI: .619–.849) were found to be comparable to those of
the text-based items for the various disorders on the Web
Screening Questionnaire (WSQ; sensitivity.72 to 1.00, specifici-
ty.44 to.77, AUC.65 to.82 [20]). According to the Donker study,
the WSQ agoraphobia item had good sensitivity (1.00), moderate
specificity (.63) and a moderate AUC (.81; 95% CI .73–.90). The
VS-CMD item also has comparable psychometric properties to a
5-item pen-and-paper questionnaire, the Fear Questionnaire
agoraphobia subscale [43]. In a clinical sample and at an optimal
cut-off point of 6, that subscale has been found to have a sensitivity
of.74 and a specificity of.72, with no AUC reported [44]. A more
accurate self-report instrument for agoraphobia is the Mobility
Inventory [45–46], especially the alone subscale. This subscale
consists of 28 items and predicts the diagnosis of agoraphobia with
sensitivity.87 and specificity.73. Comparisons between the VS-
CMD and other questionnaires [20,44,46] have limited meaning
here, as the instruments were tested in samples with characteristics
different from those of the present sample.
Our results contained 11 false positives for the VS-CMD. That
is, 11 participants clicked ‘yes’ on the VS-CMD agoraphobia item
but had not been diagnosed with agoraphobia in the CIDI
interviews. This might suggest that the agoraphobia item addresses
a common fear that is not always associated with agoraphobia,
perhaps caused by the brevity of the item. During the development
of the VS-CMD, it was challenging to translate a mental disorder
into a single question and images or animations. The DSM-IV-TR
definition of agoraphobia contains the element of fear of panic-like
symptoms, which is not covered by the VS-CMD agoraphobia
item. On the other hand, the false positives could also indicate that
11 participants had sub-clinical agoraphobia symptoms that do not
meet CIDI criteria for a diagnosis but could still be clinically
relevant. Further research into the validity of the VS-CMD should
employ continuous scale measures that gauge the severity of
symptoms, enabling the VS-CMD screening items to be compared
to various symptom severity cut-off points.
This study has a number of limitations. First, the VS-CMD was
completed after all other questionnaires (except for the diagnostic
interview). This could have biased results, as participants were
already aware what kinds of symptoms were being queried.
Second, PDSS-SR-4 rates agoraphobic avoidance in relation to
panic attacks or fear of them, whereas VS-CMD item 5 rates
agoraphobic fear. Yet the comparison between these items is valid,
because all participants suffered from either panic attacks or fear of
panic. Third, the 12-month prevalence version of the CIDI was
used, whereas the VS-CMD and the PDSS-SR assess the current
state of symptoms. This implies that the sensitivity and AUCs of
both the VS-CMD and the PDSS-SR items might have been
higher than the outcomes suggest. Fourth, our sample was limited
to people with mild to moderate panic symptoms, and the results
should therefore be generalised with caution. Samples selected for
other anxiety disorders or with more severe symptoms might have
yielded other outcomes. Finally, the study sample consisted of
Dutch people, of which half was highly educated. Considering the
VS-CMD is probably most suited for people who have difficulty
reading, this is an important limitation. Nevertheless, the present
results show that the VS-CMD measured what it was intended to
measure.
Future research should validate the other VS-CMD items, in
both patient populations and the general population, in order to
obtain more widely applicable results. If the VS-CMD proves a
valid instrument, it could be applied on Internet portals for mental
health issues in order to direct help-seekers to appropriate
information or to screen applicants on eligibility criteria for online
interventions. It could also be an alternative to text-based
questionnaires for people with low reading levels and/or various
cultural backgrounds. Very little is known about the assessment of
mental health problems among low socioeconomic, illiterate and
immigrant groups, perhaps because existing psychometric instru-
ments are difficult to understand or unsuitable in other ways [47]
or because the groups are underrepresented in research samples.
The Center for Epidemiologic Studies Depression Scale (CES-D)
[48] has been shown by a Dutch study [49] to be a valid measure
of depression among elderly Turkish and Moroccan immigrants
provided the items were read aloud to participants. Research on
the validity and utility of audiovisual screening for psychological
Single-Item Screening for Agoraphobic Symptoms
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problems in different social groups is limited. Validity can be
established only if an instrument can be compared to another
measure that has already been tested in the group being studied.
The lack of suitable instruments is one reason why the VS-CMD
was developed.
Multimedia screening is a promising area for future research.
This study shows that screening for agoraphobia may be possible
using a single multimedia item. The text-based PDSS-SR-4 may
also be a valid measure. Both items could be used to screen for
agoraphobia, while the VS-CMD item has the advantage that it
could be administered to people who have difficulty reading.
Research into the validity of web-based screening instruments and
single-item screening is still scarce, and more needs to be learned
about the use of media other than text to screen for anxiety
disorders. Further development of multimedia screening and
treatment of mental disorders should be encouraged.
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